Thyroid C-cell Tumors: In rodent scientific studies, semaglutide continues to be revealed to result in thyroid C-mobile tumors. It can be not known whether this risk applies to humans, but semaglutide is contraindicated in patients with a private or loved ones background of medullary thyroid carcinoma (MTC) or patients with Various Endocrine Neopla… Read More